Susceptibility of Hamsters to Clostridium difficile Isolates of Differing Toxinotype

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Buckley, Anthony M ^a   Spencer, Janice ^a   Maclellan, Lindsay M ^a   Candlish, Denise ^a   Irvine, June J ^a   Douce, Gillian R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CLINDAMYCIN; ERYTHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERYTHROCYTE; EX VIVO STUDY; FECES ANALYSIS; HAMSTER; HISTOLOGY; INFECTION SENSITIVITY; KINETICS; MORTALITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOME ASSESSMENT; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL SHEDDING; BACTERIAL TOXINS; CECUM; CLOSTRIDIUM DIFFICILE; COLONY COUNT, MICROBIAL; DISEASE SUSCEPTIBILITY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; KINETICS; MESOCRICETUS; MICROBIAL SENSITIVITY TESTS; SURVIVAL ANALYSIS; TELEMETRY;

EID: 84877990762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064121     Document Type: Article

References (47)

1. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL, (1977) Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 136: 701.
2. Duerden I, (2011) Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 17: 175.
3. Wilcox MH, Cunniffe JG, Trundle C, Redpath C, (1996) Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34: 23.
4. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C, (1996) Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181: 29.
5. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmée M, (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36: 2240.
6. Elliott B, Squire MM, Thean S, Chang BJ, Brazier JS, et al. (2011) New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J Med Microbiol 60: 1108.
7. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, et al. (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Gen 45: 109.
8. Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP, (2010) The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol 300: 387.
9. Petrella LA, Sambol SA, Cheknis A, Nagaro K, Kean Y, et al. (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
10. Kim H, Riley TV, Kim M, Kim CK, Yong D, et al. (2008) Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J Clin Microbiol 46: 1116.
11. Kim H, Jeong SH, Roh KH, Hong SG, Kim JW, et al. (2010) Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 30: 491.
12. Drudy D, Harnedy N, Fanning S, O'Mahony R, Kyne L, (2007) Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland. Clin Microbiol Infect 13: 298.
13. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G, (2009) Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 12: 14.
14. Huang H, Fang H, Weintraub A, Nord CE, (2009) Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 15: 1170.
15. Rousseau C, Lemée L, Le Monnier A, Poilane I, Pons JL, et al. (2011) Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 60: 1112.
16. Miyajima F, Roberts P, Swale A, Price V, Jones M, et al. (2011) Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 6: e22804.
17. Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, et al. (2012) Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control 40: 556.
18. Wilcox MH, Fawley WN, (2000) Hospital disinfectants and spore formation by Clostridium difficile. Lancet 356: 1324.
19. Nerandzic MM, Donskey CJ, (2010) Triggering germination represents a novel strategy to enhance killing of Clostridium difficile spores. PLoS One 5: e12285.
20. Kamiya S, Yamakawa K, Ogura H, Nakamura S, (1989) Recovery of spores of Clostridium difficile altered by heat or alkali. J Med Microbiol 28: 217.
21. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, et al. (2012) The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 80: 2704.
22. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192: 4904.
23. Vohra P, Poxton IR, (2011) Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157: 1343.
24. Buckley A, Spencer J, Candlish D, Irvine JJ, Douce GR, (2011) Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J Med Microbiol 60: 1174.
25. Stoesser N, Crook DW, Fung R, Griffiths D, Harding RM, et al. (2011) Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection. J Clin Microbiol 49: 3994.
26. Andrews J, (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemo 48: S15.
27. Marsh JW, O'Leary MM, Shutt KA, Pasculle AW, Johnson S, et al. (2006) Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol 44: 2558.
28. Goulding D, Thompson H, Emerson J, Fairweather NF, Dougan G, et al. (2009) Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1. Infect Immun 77: 5478.
29. Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, et al. (2012) Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 10.1007/s10096-012-1603-0.
30. Kim J, Pai H, Seo MR, Kang JO, (2012) Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis 12: 109.
31. Sambol SP, Merrigan MM, Tang JK, Johnson S, Gerding DN, (2002) Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 186: 1781.
32. Brouwer MSM, Allan E, Mullany P, Roberts AP, (2012) Draft genome sequence of the nontoxigenic Clostridium difficile strain CD37. J Bact 194: 2125.
33. Casas V, Maloy S, (2011) Role of bacteriophage-encoded exotoxins in the evolution of bacterial pathogens. Future Microbiol 6: 1461.
34. Ogura Y, Ooka T, Asadulghani, Terajima J, Nougayrède JP, et al. (2007) Extensive genomic diversity and selective conservation of virulence-determinants in enterohemorrhagic Escherichia coli strains of O157 and non-O157 serotypes. Genome Biol 8: R138.
35. Villano SA, Seiberling M, Tatarowicz W, Monnot-Chase E, Gerding DN, (2012) Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostirdium difficile Strain M3, in healthy subjects. Antimicrob Agents Chemo 56: 5224.
36. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176.
37. Kuehne S, Cartman ST, Heap JT, Kelly ML, Cockayne A, et al. (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467: 711.
38. Sambol SP, Tang JK, Merrigan MM, Johnson S, Gerding DN, (2001) Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 183: 1760.
39. Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, et al. (2010) Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139: 542.
40. Wang J, Ando T, Dunn AJ, (1997) Effect of homologous interleukin-1, interleukin-6 and tumor necrosis factor-alpha on the core body temperature of mice. Neuroimmunomodulation 4: 230.
41. Steiner TS, Flores CA, Pizarro TT, Guerrant RL, (1997) Fecal lactoferrin, interleukin-1β and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 4: 719.
42. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Associ J 171: 466.
43. Stabler R, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. (2006) Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bact 188: 7297.
44. Razaq N, Sambol S, Nagaro K, Zukowski W, Chekins A, et al. (2007) Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J Infect Dis 196: 1813.
45. Stabler R, Dawson LF, Phua LT, Wren BW, (2008) Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J Med Micro 57: 771.
46. Lanis JM, Barua S, Ballard JD, (2010) Variations in TcdB activity and the hypervirulence of emerging strains of Clsotridium difficile. PLoS Patho 6: e1001061.
47. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, et al. (2009) Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increased adherence of bacteria. PLoS Pathog 5: e1000626.